Diagnostikum
Diagnostikum is an Austrian privately held group of radiology centers operating six sites nationwide, providing MRI, CT, PET-CT, X-ray, mammography, and DEXA imaging to physician-referred and self-pay patients, with AI cancer-detection products in development.
- Company typePrivate
- Founded2005
- HeadquartersGraz, Austria
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Diagnostikum does
Diagnostikum is a privately held Austrian group of radiology centers operating six sites across Graz, Vienna (Meidling and Petscan), Linz, Schladming, and Deutschlandsberg (opening October 2025). The company provides diagnostic imaging services across modalities including MRI (MRT), CT, PET-CT, conventional X-ray, mammography, and DEXA body composition scanning, serving both social-insurance-referred patients and self-pay customers via the Private Access and MR Traun sub-brands. Referrals flow primarily through a network of physicians (Zuweiser) supported by dedicated online portals at each site, with direct online appointment booking available to patients.
The group operates the world's first Siemens Healthineers Naeotom Alpha Prime CT scanner, installed at the Graz headquarters in September 2024 and described as a quantum leap in imaging technology. Through the A.I.gnostikum subsidiary, developed in collaboration with TU Graz, Diagnostikum is advancing two AI-MR products for breast and prostate cancer detection toward certification, signaling an extension from clinical imaging services into AI-augmented diagnostics. Sub-brands include Private Access and MR Traun for no-wait-time premium imaging, Diagnostikum Primärversorgung (PV) for primary care CT investigations, and a DEXA body composition service. Leadership comprises multiple university professors, with a collective scientific output of 400+ international publications and approximately 600 presentations, supporting a research-driven clinical positioning.
Diagnostikum is organized across five Austrian legal entities (GmbH/GesmbH) with no disclosed external investors, parent company, or funding rounds. Revenue derives from professional-services fees on imaging examinations, supplemented by self-pay premium services and primary-care CT offerings. Certifications include TÜV SÜD, UEMS nuclear medicine, and Früh Erkennen. The combination of multi-modality depth, capital-intensive first-of-kind technology, and a university-affiliated medical leadership underpins a regionally differentiated position in Austrian outpatient radiology.
Diagnostikum firmographics
Firmographics- Name
- Diagnostikum
- Legal name
- Diagnostikum Graz Süd West GmbH
- Website
- https://diagnostikum.at
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Diagnostikum is an Austrian privately held group of radiology centers operating six sites nationwide, providing MRI, CT, PET-CT, X-ray, mammography, and DEXA imaging to physician-referred and self-pay patients, with AI cancer-detection products in development.
- Ownership category
- akta.pro rank
Diagnostikum industry classification
Industry- Product category
- Diagnostic Imaging Services
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)
- akta.pro secondary industries
- Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
Keywords
Where Diagnostikum is headquartered
LocationHeadquarters
- HQ city
- Graz
- HQ country
- Austria
- HQ region
- Europe
Offices6 records
Markets served
Diagnostikum business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Imaging Services: Core revenue from providing medical diagnostic imaging services including MRI, CT, PET-CT, X-ray, mammography, and DEXA scans to patients referred by physicians. Services include both standard and private access options.
- Private Access Services: Premium diagnostic imaging services without waiting times through the Private Access offering, providing faster results for patients willing to pay for expedited service.
- Primary Care Centers (PVZ): Revenue from primary care centers (Primärversorgungseinheiten) offering CT and MRI investigations as part of integrated healthcare services.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
Diagnostikum product offering
Product offeringCore offering
Diagnostikum operates a group of physical radiology centers in Austria that deliver medical diagnostic imaging examinations including MRI, CT, PET-CT, X-ray, mammography, and DEXA body composition scanning. Services are provided to physician-referred patients and to self-paying patients through a premium "Private Access" offering that bypasses waiting times. The group also operates MR Traun (dedicated MRI), Diagnostikum Primärversorgung (primary-care CT), and the A.I.gnostikum startup developing AI-assisted breast and prostate cancer detection.
Product overview
Diagnostikum is a group of leading radiology centers across Austria offering a comprehensive portfolio of medical imaging services. The core offering consists of multiple physical locations (Graz, Vienna, Linz, Schladming, Deutschlandsberg) providing diagnostic imaging including MRT (MRI), CT, PET-CT, X-ray, mammography, and DEXA body composition scanning. The group operates sub-brands including A.I.gnostikum (AI-powered cancer detection from medical images in development), MR Traun (dedicated MRI services without wait times), Private Access (priority imaging services), and Diagnostikum Primärversorgung (primary care CT). Supporting services include an online referrer portal for physicians to access patient results, a radiology technology scholarship program, and a publications repository showcasing over 400 international scientific publications. The group recently installed Austria's first Siemens Naeotom Alpha Prime CT scanner and is developing AI-MR products for breast and prostate cancer detection in collaboration with TU Graz.
Differentiator
Problem solved
Functional benefit
Brands
- Private Access: Private diagnostic imaging services offered without waiting time
- A.I.gnostikum
- Diagnostikum Primärversorgung
- MR Traun
- Diagnostikum PV Standorte
Products and services
- MRI (Magnetresonanztomografie / MRT) diagnostic imaging
Quantifiable outcome
- Over 99% of patients tolerate contrast media well during CT examinations
- +2 more outcomes
Companies that use Diagnostikum
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Diagnostikum technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
Diagnostikum partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Siemens HealthineerscoreSiemens Healthineers partnership provides access to state-of-the-art imaging technology, including the installation of the Naeotom Alpha Prime CT at Diagnostikum Graz in September 2024. This represents a significant technology advantage as it is described as the world's first such CT scanner using groundbreaking new technology for medical imaging.
- Technische Universität Graz (TU Graz)coreCollaboration with TU Graz for the A.I.gnostikum startup focused on medical data processing and AI development in radiology. The partnership is developing AI-MR products for breast and prostate cancer detection, with two products nearing certification. This represents significant innovation investment in AI-powered diagnostics.
- Klinik Diakonissen SchladmingminorDiagnostikum Schladming is located within the Klinik Diakonissen Schladming facility, enabling integrated healthcare delivery with the hospital's other medical services.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
Diagnostikum competitors and assessment
Company assessmentDirect peers
- Synlab: Leading European provider of medical diagnostics including imaging and laboratory services across 30+ countries. Overlap with Diagnostikum in operating outpatient diagnostic centers serving referring physicians and self-pay patients.
- Global Diagnostics (formerly known as InHealth): European diagnostic imaging provider operating MRI, CT, and other modalities across multiple countries. Direct peer in outpatient diagnostic imaging business model and referral-driven GTM.
- Evidia (formerly Atos Medical/Imaging): European imaging center operator focused on MRI, CT, and other radiology services. Directly comparable business model, modality mix, and physician referral-driven outpatient imaging footprint.
- Affidea: Pan-European operator of diagnostic imaging and outpatient centers (MRI, CT, PET-CT) across 15+ countries. Closest direct peer to Diagnostikum in terms of multi-site imaging center model, modality mix, and physician-referral GTM across Europe.
- RAYUS Radiology: One of the largest U.S. outpatient imaging networks operating 150+ centers across MRI, CT, PET-CT, and other modalities. Highly comparable multi-site imaging center model, though U.S.-based payer mix differs.
- Unilabs: One of Europe's largest diagnostic services groups offering imaging and laboratory diagnostics across multiple countries. Comparable to Diagnostikum via multi-modality outpatient diagnostic services and physician-driven referral networks, though heavier in lab work.
Broad incumbents
- Radiology Partners: Largest physician-led radiology practice in the U.S., operating as a broad radiology group across hundreds of sites. Comparable to Diagnostikum in physician-led outpatient radiology services, but at substantially greater scale and primarily U.S. exposure.
- Medicover: European healthcare services group with diagnostic and outpatient service lines across Central/Eastern Europe. Broader healthcare operator with overlapping diagnostic services exposure but wider service portfolio.
Regional players
- VAMED: Austrian-headquartered healthcare services provider spanning hospital planning, operations, and diagnostic services across Central Europe. Relevant regional comparable operating in the same Austrian healthcare ecosystem as Diagnostikum.
Emerging players
- Qure.ai: AI radiology company developing deep-learning models for image-based diagnosis across multiple modalities. Relevant to Diagnostikum's A.I.gnostikum business as a benchmark competitor in AI-augmented radiology diagnostics.
Market position
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Diagnostikum social profiles
Digital presenceDiagnostikum financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diagnostikum leadership team
Management profileNumber of profiles
Profiles6 records
Diagnostikum subsidiaries and ownership
Company hierarchySubsidiaries8 records
Diagnostikum funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diagnostikum M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diagnostikum
What does Diagnostikum do?
Diagnostikum operates a group of physical radiology centers in Austria that deliver medical diagnostic imaging examinations including MRI, CT, PET-CT, X-ray, mammography, and DEXA body composition scanning. Services are provided to physician-referred patients and to self-paying patients through a premium "Private Access" offering that bypasses waiting times. The group also operates MR Traun (dedicated MRI), Diagnostikum Primärversorgung (primary-care CT), and the A.I.gnostikum startup developing AI-assisted breast and prostate cancer detection.
Is Diagnostikum a public or private company?
Diagnostikum is a private company. It is classified as management employee owned and is currently operating.
When was Diagnostikum founded?
Diagnostikum was founded in 2005. It employs 51 to 100 people.
Where is Diagnostikum based?
Diagnostikum is headquartered in Graz, Austria, in the Europe region.
How does Diagnostikum make money?
Three revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are private Access Services and primary Care Centers (PVZ).
Who are Diagnostikum's main competitors?
Direct peers on record are Synlab, Global Diagnostics (formerly known as InHealth), Evidia (formerly Atos Medical/Imaging), Affidea, RAYUS Radiology and Unilabs. Broad incumbents are Radiology Partners and Medicover. VAMED is listed as a regional player. Qure.ai is listed as an emerging player.
Does Diagnostikum have an API?
No public API is recorded for Diagnostikum.
What industry is Diagnostikum in?
Diagnostikum's product category is Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology). Its NAICS code is 621512 and its SIC code is 8000.